Plus Therapeutics Presents Positive Data from Ongoing ReSPECT™ Clinical Trials at the Annual Conference on CNS Clinical Trials and Brain Metastases

Written by Customer Service on August 13, 2022. Posted in Public Companies.

AUSTIN, Texas, Aug. 13, 2022 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, yesterday presented positive data from two ongoing clinical trials of its lead investigational drug, Rhenium-186 Nanoliposome (186RNL), in the treatment of recurrent glioblastoma (GBM) and leptomeningeal metastases (LM) at the 2022 Annual Conference on CNS Clinical Trials and Brain Metastases. The conference is co-sponsored by the Society for Neuro-Oncology (SNO) and the American Society of Clinical Oncology (ASCO) and is being held August 12-13, 2022 in Toronto, Canada. The oral presentation, titled Safety and Feasibility of Rhenium-186 Nanoliposome (186RNL) in Leptomeningeal Metastases Phase 1/2a...

Prime Mining Announces Financial Results

Written by Customer Service on August 13, 2022. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, Aug. 12, 2022 (GLOBE NEWSWIRE) — Prime Mining Corp. (“Prime”, or the “Company”) (TSX.V: PRYM) (OTCQB: PRMNF) (Frankfurt: O4V3) is pleased to report its operating and financial results for the three-month period ending June 30, 2022. Unless otherwise stated, all amounts are presented in Canadian dollars. Prime is focused on the exploration and development of its wholly owned Los Reyes Gold-Silver Project in Sinaloa State, Mexico (“Los Reyes” or the “Project”). Prime Chief Executive Officer Daniel Kunz commented, “We are currently into the rainy season at Los Reyes but still have 5 drill rigs operating and already have completed 63,000 metres of drilling in Phase 2, for a total of 88,500 metres Phase 1 and 2 combined. In July 2022, the Company reported results from eight drill holes at the San Miguel...

Diversified Royalty Corp. Announces Strongest Adjusted Revenue(1) Quarter in its History

Written by Customer Service on August 13, 2022. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, Aug. 12, 2022 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV; DIV.DB and DIV.DB.A) (the “Corporation” or “DIV”) is pleased to announce its financial results for the three months ended June 30, 2022 (“Q2 2022”) and six months ended June 30, 2022. Q2 2022 Highlights Revenue of $11.1 million in Q2 2022 (DIV’s strongest revenue quarter since adopting its multi-royalty strategy in 2013) and $20.8 million for the six months ended June 30, 2022, up 20.8% compared to the three months ended June 30, 2021 (“Q2 2021”) and 24.1% compared to the six months ended June 30, 2021. Adjusted revenue1 of $12.3 million in Q2 2022 and $23.3 million for the six months ended June 30, 2022, up 18.6% and 21.3%, respectively, compared to the same periods in 2021. Distributable cash1 of $7.9 million in Q2 2022 and $15.1...

Day: August 13, 2022